Presidio Pharmaceuticals, Inc. to Present at the Canaccord Adams' Hepatitis C Conference
SAN FRANCISCO--(BUSINESS WIRE)--Mar 29, 2010 - Presidio Pharmaceuticals, Inc. announced today that Dr. Omar K. Haffar, Founder, President and Chief Executive Officer, will present an update on Presidio's drug development activities at the Canaccord Adams Hepatitis C Conference on Thursday, April 1, 2010 at 2:30PM in the Tribeca Room at the Peninsula Hotel in New York City.
Presidio Pharmaceuticals, Inc. is a San Francisco-based specialty pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics for novel and validated targets. For more information, please visit our website at: www.presidiopharma.com.
Contact: Presidio Pharmaceuticals, Inc.
Omar K. Haffar, PhD, 415-655-7561
Posted: March 2010